Gemcitabine, Etoposide, Cisplatin, and Dexamethasone in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma

BACKGROUND/AIMS: To date, an effective salvage chemotherapy regimen for the treatment of refractory or relapsing non-Hodgkin's lymphoma (NHL) has not been discovered. This study was conducted to evaluate the efficacy and safety of gemcitabine, etoposide, cisplatin, and dexamethasone in relapsed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ki-Hyang, Joo, Young-Don, Sohn, Chang-Hak, Shin, Ho-Jin, Chung, Joo-Seop, Cho, Goon-Jae, Shin, Sung-Hoon, Kim, Yang-Soo, Lee, Won-Sik
Formato: Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687646/
https://www.ncbi.nlm.nih.gov/pubmed/19270480
http://dx.doi.org/10.3904/kjim.2009.24.1.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687646/
https://www.ncbi.nlm.nih.gov/pubmed/19270480
http://dx.doi.org/10.3904/kjim.2009.24.1.37

Ejemplares similares